bf/NASDAQ:COYA_icon.jpeg

NASDAQ:COYA

Coya Therapeutics, Inc.

  • Stock

USD

Last Close

5.90

30/08 20:00

Market Cap

102.29M

Beta: -

Volume Today

4.79K

Avg: 49.57K

PE Ratio

−4.94

PFCF: −5.88

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
net income
-733.20K
-
-4.89M
567.19%
-12.24M
150.31%
-7.99M
34.77%
depreciation and amortization
16.13K
-
27.36K
69.60%
27.36K
0%
deferred income tax
399.68K
-
-298.82K
-
stock based compensation
233.22K
-
207.35K
11.10%
872.25K
320.67%
change in working capital
77.95K
-
739.17K
848.22%
751.84K
1.71%
-4.64M
717.66%
accounts receivables
-7.50M
-
inventory
accounts payables
105.22K
-
665.17K
532.17%
845.28K
27.08%
298.82K
64.65%
other working capital
-27.27K
-
74.00K
371.40%
-93.45K
226.27%
2.56M
2,836.78%
other non cash items
263.98K
-
-399.68K
251.41%
4.02M
1,105.53%
842.00K
79.05%
net cash provided by operating activities
-391.27K
-
-3.90M
897.60%
-7.24M
85.47%
-11.19M
54.56%
investments in property plant and equipment
-136.80K
-
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
-525K
-
-543.19K
3.46%
net cash used for investing activites
-136.80K
-
-525K
283.76%
-543.19K
3.46%
debt repayment
-9.47M
-
common stock issued
9.11M
-
1.32K
99.99%
158
88.00%
38.43M
24,319,560.13%
common stock repurchased
dividends paid
other financing activites
400
-
-341.90K
85,575.25%
18.83M
5,607.24%
net cash used provided by financing activities
9.11M
-
-340.58K
103.74%
9.36M
2,847.60%
38.43M
310.62%
effect of forex changes on cash
net change in cash
8.72M
-
-4.38M
150.23%
1.59M
136.38%
26.69M
1,575.10%
cash at beginning of period
8.72M
-
4.34M
50.23%
5.93M
36.72%
cash at end of period
8.72M
-
4.34M
50.23%
5.93M
36.72%
32.63M
449.86%
operating cash flow
-391.27K
-
-3.90M
897.60%
-7.24M
85.47%
-11.19M
54.56%
capital expenditure
-136.80K
-
free cash flow
-391.27K
-
-4.04M
932.56%
-7.24M
79.19%
-11.19M
54.56%

All numbers in USD (except ratios and percentages)